| http://www.w3.org/ns/prov#value | - Although the various studies differ in some respects, such as the length of follow-up, extent of prior experience with antiretroviral agents, and inclusion or exclusion of expert advice, these trials generally show a moderate virologic benefit with the use of genotypic resistance assays.[7,8,9,10,11] Less data are available regarding the utility of the phenotypic assay.
|
